The Australia Continuous Positive Airway Pressure (CPAP) machines market is experiencing rapid growth, with increasing sleep apnea awareness, advancement in technology, and growing home-based healthcare. In 2024, over 9% of the country’s population is experiencing sleep apnea, thus driving the demand for CPAP devices. The market is dominated by fixed-pressure CPAP devices, accounting for 68% of the market share. Meanwhile, demand for auto-adjusting CPAP (APAP) devices and Bi-level Positive Airway Pressure (BiPAP) devices are also rising due to their advanced features including real-time pressure adjustments and improved patient comfort. The CPAP market is set to play important role in country’s healthcare technology landscape.
What’s Driving the CPAP Machine Market in Australia?
- The rising Obstructive Sleep Apnea (OSA) is directly benefiting the CPAP market as economic burden is pushing healthcare providers and policymakers to promote early diagnosis and treatment. In 2024, 1.5 million Australians experienced OSA with repeated breathing interruptions during sleep, often accompanied by snoring, daytime fatigue, and cardiovascular risks. This rising health challenge is driving the demand for CPAP therapy in order to prevent long-term health risks.
- The rapid technological advancement is fueling the CPAP machine market by addressing major barrier of patient comfort and therapy adherence. The modern CPAP devices offer variety of features including auto-adjusting pressure, integrated humidifiers, remote monitoring and mobile connectivity, and noise cancelation and compact design. These advanced features boost adherence rates by 20-30% compared to traditional models.
- The growing home-based sleep testing, driven by advancement in diagnostic technology is shifting consumer preferences. Home-based testing allows patient to undergo sleep studies at their own comfort, leading to high accurate data collection and diagnosis. Therefore, increasing demand for CPAP devices and therapy.
Market Competition
The Australia CPAP machine market is highly competitive with few major players including ResMed Inc, Philips Respironics, and Fisher & Paykel Healthcare dominating the landscape. ResMed Inc is a leading player and has reported 34% increase in quarterly operating profits in 2024. The company developed AirTouch N30i which is fully fabric sleep apnea mask designed to enhance user comfort and integration into daily life. Philips Respironics focuses on restoring consumer trust by introducing new and compliant products to meet market demand. Meanwhile, Fisher & Paykel Healthcare has witnessed revenue growth of 5% in homecare segment in 2024. The company’s SleepStyle CPAP machine and the Evora Full Face Mask are known for their comfort and user-friendly features.
Impact of Weight-Loss Medications on the CPAP Market
The rising popularity of GLP-1 receptor agonist weight-loss drugs like Ozempic (semaglutide), Wegovy, and Zepbound (tirzepatide) are creating challenge for Australia CPAP machine market. These medications reduce severity of obstructive sleep apnea (OSA), promoting weight loss among obese patients. As of 2025, 70% of the individuals with OSA are obese, making weight loss a critical factor in OSA management. Analysts projected that GLP-1 drugs could reduce the total addressable market for CPAP devices by up to 15% over the next three years.
Future Outlook
The Australia CPAP machine market will experience major transformations through 2030. Technological innovations will continue to enhance patient compliance and therapy. The integration of CPAP devices with digital health platforms allows remote monitoring and data analysis. This integration is expected to enhance therapy adherence and patient engagement. The sleep testing in Australia is expected to increase by 48% till 2030, highlighting the growing preference for at-home diagnostic solutions. Furthermore, growing health awareness and country’s rising aging population will continue to accelerate the CPAP machine market in Australia.
Consultant at Nexdigm In their latest publication “Australia CPAP Machine Market Outlook to 2030: By Modality (Portable, Standalone), By Product Type (Consumable, CPAP Device), and By End User (Private Clinics, Hospitals, Home Care, and Others)” believe that prioritizing digital health integration and strengthening partnerships with healthcare providers can help businesses in gaining competitive advantage in Australia CPAP machine market.